Shane Storey
Stock Analyst at Canaccord Genuity
(3.04)
# 2,609
Out of 5,081 analysts
353
Total ratings
46.7%
Success rate
2.1%
Average return
Main Sectors:
Stocks Rated by Shane Storey
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASX: TLX Telix Pharmaceuticals Limited | Reiterated: Buy | $31.50 | $12.86 | +145.04% | 59 | Oct 2, 2026 | |
| ASX: CSL CSL Limited | Reiterated: Hold | $185.00 | $194.78 | -5.02% | 30 | Oct 1, 2026 | |
| ASX: RMD ResMed Inc. | Reiterated: Buy | $40.00 | $35.84 | +11.61% | 22 | Sep 28, 2026 | |
| ASX: ACW Actinogen Medical Limited | Reiterated: Buy | $0.08 | $0.04 | +90.48% | 6 | Sep 3, 2026 | |
| ASX: SOM SomnoMed Limited | Reiterated: Buy | $1.00 → $0.76 | $0.30 | +153.33% | 23 | Aug 31, 2026 | |
| ASX: PNV PolyNovo Limited | Downgraded: Hold | $1.58 → $0.95 | $0.85 | +11.44% | 17 | Aug 27, 2026 | |
| NZE: FPH Fisher & Paykel Healthcare Corporation Limited | Reiterated: Buy | $46.19 → $44.96 | $48.37 | -7.05% | 16 | May 27, 2026 | |
| ASX: ARX Aroa Biosurgery Limited | Reiterated: Buy | $1.16 → $1.35 | $0.53 | +154.72% | 28 | May 3, 2026 | |
| ASX: COH Cochlear Limited | Reiterated: Buy | $295.00 → $120.00 | $139.59 | -14.03% | 19 | Apr 29, 2026 | |
| ASX: MVF Monash IVF Group Limited | Reiterated: Hold | $0.69 → $0.86 | $0.71 | +21.13% | 20 | Apr 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1.33 → $1.26 | $0.52 | +144.66% | 2 | Apr 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3.00 → $2.57 | $2.10 | +22.38% | 12 | Mar 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5.43 → $5.55 | $3.12 | +78.17% | 21 | Mar 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $3.85 → $2.40 | $2.96 | -18.92% | 3 | Feb 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $0.07 → $0.06 | $0.00 | +1,400.00% | 22 | Feb 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $350.00 | $198.79 | +76.07% | 5 | Nov 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $0.85 → $0.80 | $0.25 | +220.00% | 4 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $37.00 | $54.65 | n/a | 11 | Oct 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $32.84 | $7.20 | n/a | 3 | Sep 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3.00 → $2.81 | $0.13 | n/a | 4 | Sep 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1.20 | $0.02 | n/a | 2 | Sep 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3.00 | $1.91 | n/a | 3 | Sep 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26.50 | $18.92 | n/a | 1 | Aug 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8.50 | $1.60 | n/a | 7 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1.00 | $0.01 | n/a | 2 | Mar 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $5.95 → $7.40 | $2.42 | n/a | 2 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $0.71 → $0.55 | $0.49 | n/a | 3 | Feb 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $0.17 → $0.06 | $0.74 | n/a | 2 | Sep 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $0.50 → $0.55 | $0.07 | n/a | 3 | Aug 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $0.75 | $0.01 | n/a | 1 | Jun 1, 2022 |
Telix Pharmaceuticals Limited
Oct 2, 2026
Reiterated: Buy
Price Target: $31.50
Current: $12.86
Upside: +145.04%
CSL Limited
Oct 1, 2026
Reiterated: Hold
Price Target: $185.00
Current: $194.78
Upside: -5.02%
ResMed Inc.
Sep 28, 2026
Reiterated: Buy
Price Target: $40.00
Current: $35.84
Upside: +11.61%
Actinogen Medical Limited
Sep 3, 2026
Reiterated: Buy
Price Target: $0.08
Current: $0.04
Upside: +90.48%
SomnoMed Limited
Aug 31, 2026
Reiterated: Buy
Price Target: $1.00 → $0.76
Current: $0.30
Upside: +153.33%
PolyNovo Limited
Aug 27, 2026
Downgraded: Hold
Price Target: $1.58 → $0.95
Current: $0.85
Upside: +11.44%
Fisher & Paykel Healthcare Corporation Limited
May 27, 2026
Reiterated: Buy
Price Target: $46.19 → $44.96
Current: $48.37
Upside: -7.05%
Aroa Biosurgery Limited
May 3, 2026
Reiterated: Buy
Price Target: $1.16 → $1.35
Current: $0.53
Upside: +154.72%
Cochlear Limited
Apr 29, 2026
Reiterated: Buy
Price Target: $295.00 → $120.00
Current: $139.59
Upside: -14.03%
Monash IVF Group Limited
Apr 29, 2026
Reiterated: Hold
Price Target: $0.69 → $0.86
Current: $0.71
Upside: +21.13%
Apr 20, 2026
Reiterated: Buy
Price Target: $1.33 → $1.26
Current: $0.52
Upside: +144.66%
Mar 4, 2026
Reiterated: Buy
Price Target: $3.00 → $2.57
Current: $2.10
Upside: +22.38%
Mar 4, 2026
Reiterated: Buy
Price Target: $5.43 → $5.55
Current: $3.12
Upside: +78.17%
Feb 17, 2026
Downgraded: Hold
Price Target: $3.85 → $2.40
Current: $2.96
Upside: -18.92%
Feb 2, 2026
Reiterated: Buy
Price Target: $0.07 → $0.06
Current: $0.00
Upside: +1,400.00%
Nov 18, 2025
Reiterated: Buy
Price Target: $350.00
Current: $198.79
Upside: +76.07%
Nov 7, 2025
Reiterated: Buy
Price Target: $0.85 → $0.80
Current: $0.25
Upside: +220.00%
Oct 3, 2025
Reiterated: Hold
Price Target: $37.00
Current: $54.65
Upside: n/a
Sep 24, 2025
Reiterated: Buy
Price Target: $32.84
Current: $7.20
Upside: n/a
Sep 11, 2025
Reiterated: Buy
Price Target: $3.00 → $2.81
Current: $0.13
Upside: n/a
Sep 10, 2025
Reiterated: Buy
Price Target: $1.20
Current: $0.02
Upside: n/a
Sep 2, 2025
Reiterated: Buy
Price Target: $3.00
Current: $1.91
Upside: n/a
Aug 28, 2025
Reiterated: Buy
Price Target: $26.50
Current: $18.92
Upside: n/a
Aug 8, 2025
Reiterated: Buy
Price Target: $8.50
Current: $1.60
Upside: n/a
Mar 24, 2025
Reiterated: Hold
Price Target: $1.00
Current: $0.01
Upside: n/a
Feb 27, 2025
Downgraded: Hold
Price Target: $5.95 → $7.40
Current: $2.42
Upside: n/a
Feb 21, 2023
Reiterated: Hold
Price Target: $0.71 → $0.55
Current: $0.49
Upside: n/a
Sep 2, 2022
Downgraded: Hold
Price Target: $0.17 → $0.06
Current: $0.74
Upside: n/a
Aug 29, 2022
Reiterated: Hold
Price Target: $0.50 → $0.55
Current: $0.07
Upside: n/a
Jun 1, 2022
Reiterated: Buy
Price Target: $0.75
Current: $0.01
Upside: n/a